mitoxantrone has been researched along with Lymphopenia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Lymphopenia: Reduction in the number of lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Webb, M | 1 |
| Tham, CS | 1 |
| Lin, FF | 1 |
| Lariosa-Willingham, K | 1 |
| Yu, N | 1 |
| Hale, J | 1 |
| Mandala, S | 1 |
| Chun, J | 1 |
| Rao, TS | 1 |
1 other study available for mitoxantrone and Lymphopenia
| Article | Year |
|---|---|
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Inter | 2004 |